Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT01914263
What this trial is testing

Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection

Who this might be right for
Hepatocellular CarcinomaRenal Cell CarcinomaLung Cancer
Alliancells-PuRui Biocience Co., Ltd. 40
Not applicableNo Longer AvailableNCT03554434
What this trial is testing

An Expanded Access Program for AM0010 (Pegilodecakin)

Who this might be right for
MelanomaProstate CancerOvarian Cancer+6 more
Eli Lilly and Company
Testing effectiveness (Phase 2)Study completedNCT00630409
What this trial is testing

Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
University of Pittsburgh 5
Testing effectiveness (Phase 2)Looking for participantsNCT05888532
What this trial is testing

64Cu-GRIP B in Patients With Advanced Malignancies

Who this might be right for
Prostate CancerRenal CancerUrethral Cancer+3 more
Rahul Aggarwal 91
Early research (Phase 1)Study completedNCT04544748
What this trial is testing

GNR-051 in Subjects With Advanced Malignancies

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Renal CellMelanoma
AO GENERIUM 48
Not applicableStudy completedNCT02457715
What this trial is testing

Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral Sclerosis

Who this might be right for
Prostate CancerRenal CancerBrain Cancer+1 more
Duke University 40
Not applicableLooking for participantsNCT06076538
What this trial is testing

PET/MR for Characterization of Renal Masses (RMs)

Who this might be right for
Renal TumorRenal Cell CarcinomaRenal Tumor, Benign
University of Texas Southwestern Medical Center 97
Testing effectiveness (Phase 2)WithdrawnNCT00040989
What this trial is testing

BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer

Who this might be right for
Stage IV Renal Cell CancerRecurrent Renal Cell Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07551349
What this trial is testing

Dual-target CD70/CAIX CAR-NK Cells for Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Beijing Biotech 36
Not applicableUnknownNCT04503148
What this trial is testing

Anesthesia and Cancer Study: Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Seoul National University Hospital 562
Testing effectiveness (Phase 2)Ended earlyNCT02859415
What this trial is testing

Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases

Who this might be right for
Esophageal NeoplasmsLung NeoplasmsMesothelioma+2 more
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Study completedNCT00193258
What this trial is testing

Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
SCRI Development Innovations, LLC 94
Early research (Phase 1)WithdrawnNCT00006126
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery

Who this might be right for
Breast CancerKidney CancerLung Cancer+2 more
Northwestern University
Not applicableNo Longer AvailableNCT01473043
What this trial is testing

Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment

Who this might be right for
Renal Cell Carcinoma
Pfizer
Testing effectiveness (Phase 2)Ended earlyNCT01888042
What this trial is testing

Assessing Everolimus in Fist Line Treatment on Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Gustave Roussy, Cancer Campus, Grand Paris 61
Not applicableStudy completedNCT01441661
What this trial is testing

Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Cancer Foundation, China 400
Early research (Phase 1)Looking for participantsNCT07419841
What this trial is testing

The Safety and Tolerability of CTX-10726

Who this might be right for
Gastroesophageal Cancer (GC)Hepatocellular Carcinoma (HCC)Endometrial Cancer+1 more
Compass Therapeutics 70
Testing effectiveness (Phase 2)Study completedNCT00027573
What this trial is testing

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
Alliance for Clinical Trials in Oncology 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT03541902
What this trial is testing

Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma

Who this might be right for
Malignant Neoplasms of Urinary TractRenal Cell CarcinomaChromophobe Renal Cell Carcinoma+6 more
M.D. Anderson Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT02915783
What this trial is testing

A Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease

Who this might be right for
Non Clear Cell Renal Cell Carcinoma (nccRCC)
Eisai Inc. 41
Next Page